|
π
|
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
82 auth.
S. Vasaikar,
Chen Huang,
Xiaojing Wang,
V. Petyuk,
Sara R. Savage,
Bo Wen,
Yongchao Dou,
Yun Zhang,
Zhiao Shi,
O. A. Arshad,
M. Gritsenko,
L. Zimmerman,
Jason E. McDermott,
T. Clauss,
Ronald J. Moore,
...
R. Zhao,
M. Monroe,
Yi-Ting Wang,
Matthew C Chambers,
R. Slebos,
Ken S. Lau,
Qianxing Mo,
L. Ding,
M. Ellis,
M. Thiagarajan,
C. Kinsinger,
H. Rodriguez,
Richard D. Smith,
K. Rodland,
Daniel C. Liebler,
Tao Liu,
Bing Zhang,
Akhilesh Pandey,
A. Paulovich,
Andrew N. Hoofnagle,
D. Mani,
Daniel W. Chan,
D. Ransohoff,
D. Fenyo,
David L. Tabb,
Douglas A. Levine,
Emily Boja,
E. Kuhn,
Forest M. White,
Gordon A. Whiteley,
Heng Zhu,
Hui Zhang,
I. Shih,
Jasmin H. Bavarva,
Jeffrey R. Whiteaker,
K. Ketchum,
K. Clauser,
Kelly V. Ruggles,
Kim Elburn,
L. Hannick,
Mark A. Watson,
Mauricio Oberti,
M. Mesri,
Melinda E. Sanders,
M. Borucki,
Michael A. Gillette,
Michael Snyder,
Nathan Edwards,
Negin Vatanian,
P. Rudnick,
P. McGarvey,
Philipp Mertins,
R. R. Townsend,
Ratna R. Thangudu,
Robert C. Rivers,
S. Payne,
Sherri R Davies,
Shuang Cai,
Stephen E. Stein,
Steve Carr,
Steven J. Skates,
Subha Madhavan,
Tara Hiltke,
Xian Chen,
Ying Zhao,
Yue Wang,
Zhen Zhang
|
9 |
2019 |
9
π
|
|
π
|
Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-Ξ±
19 auth.
L. Tezera,
M. Bielecka,
P. Ogongo,
N. Walker,
M. Ellis,
D. Garay-Baquero,
Kristian Thomas,
Michaela T. Reichmann,
D. Johnston,
K. Wilkinson,
...
Mohamed I. M. Ahmed,
S. Jogai,
S. Jayasinghe,
R. Wilkinson,
S. Mansour,
G. Thomas,
C. Ottensmeier,
A. Leslie,
P. Elkington
|
6 |
2020 |
6
π
|
|
π
|
Validation of Immune Cell Modules in Multicellular Transcriptomic Data
9 auth.
G. Pollara,
M. Murray,
J. Heather,
R. Byng-Maddick,
N. Guppy,
M. Ellis,
...
Carolin T. Turner,
B. Chain,
M. Noursadeghi
|
4 |
2017 |
4
π
|
|
π
|
Tumor Necrosis Factor (TNF) Bioactivity at the Site of an Acute Cell-Mediated Immune Response Is Preserved in Rheumatoid Arthritis Patients Responding to Anti-TNF Therapy
8 auth.
R. Byng-Maddick,
Carolin T. Turner,
G. Pollara,
M. Ellis,
N. Guppy,
L. C. Bell,
...
M. Ehrenstein,
M. Noursadeghi
|
3 |
2017 |
3
π
|
|
π
|
JAML immunotherapy targets recently activated tumor-infiltrating CD8+ TΒ cells.
13 auth.
S. Eschweiler,
Alice Wang,
C. RamΓrez-SuΓ‘stegui,
A. von Witzleben,
Yingcong Li,
S. Chee,
Hayley Simon,
M. Mondal,
M. Ellis,
G. Thomas,
...
Vivek Chandra,
C. Ottensmeier,
P. Vijayanand
|
3 |
2023 |
3
π
|
|
π
|
Author response: Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-Ξ±
19 auth.
L. Tezera,
M. Bielecka,
P. Ogongo,
N. Walker,
M. Ellis,
D. Garay-Baquero,
Kristian Thomas,
Michaela T. Reichmann,
D. Johnston,
K. Wilkinson,
...
M. Ahmed,
S. Jogai,
S. Jayasinghe,
R. Wilkinson,
S. Mansour,
G. Thomas,
C. Ottensmeier,
A. Leslie,
P. Elkington
|
1 |
2020 |
1
π
|
|
π
|
216.4: Wide Spectrum of Molecular Injury Highlights Heterogeneity of Banff Tubulitis and Interstitial Inflammation Lesions
10 auth.
F. Shihab,
D. Brennan,
M. Ellis,
T. T. Maw,
Nikhil Agrawal,
Grigory Shekhtman,
...
Eric Stites,
J. Zeng,
E. Huang,
S. Kung
|
0 |
2022 |
0
π
|
|
π¬
|
Intratumoural immune signature to identify patients with primary colorectal cancer who do not require follow-up after resection: an observational study.
J. Primrose,
S. Pugh,
G. Thomas,
M. Ellis,
K. Moutasim,
D. Mant
|
0 |
2021 |
0
π¬
|
|
π
|
P1203: THE OPTIMIZED HLH INFLAMMATORY (OHI) INDEX IDENTIFIES LYMPHOMA PATIENTS WITH UNEXPECTEDLY HIGH MORTALITY NOT RELATED TO DISEASE PROGRESSION
22 auth.
A. Zoref-Lorenz,
J. Murakami,
L. Hofstetter,
U. Abadi,
S. Iyer,
S. Mohamed,
P. Miller,
A. E. Natour,
S. Weinstein,
J. Yacobovich,
...
S. Izraeli,
S. Nikiforow,
B. Ebert,
R. Gurion,
I. Cohen,
O. Pasvolsky,
P. Raanani,
A. Nagler,
N. Berliner,
N. Daver,
M. Ellis,
M. Jordan
|
0 |
2022 |
0
π
|
